Delivery Order SPE2DB22D1002-SPE2DB25FLCZ4
- Not listed
- The Defense Logistics Agency (DLA) awarded a $2,475.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment, with an ultimate completion date of September 29, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,980.16 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment (UDGM) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,945.13 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed price contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a straightforward pharmaceutical procurement executed through AmerisourceBergen's existing contract vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,084.30 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5 gram units. This firm fixed-price delivery order, awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, represents a non-set-aside, competitively awarded contract. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen Drug Corp's corporate office. AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $1,022.75, is scheduled for completion by October 15, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% eye ointment in 3.5-gram units, with a contract value of $1,362.97 and an ultimate completion date of July 30, 2025. This non-set-aside award reflects a competitive procurement process and represents a delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at approximately $1 billion through December...
- The U.S. Defense Logistics Agency Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,507.60 and has an ultimate completion date of September 3, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,499.80 to AmerisourceBergen Drug Corp for erythromycin 0.5% eye ointment, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen Drug Corp's larger pharmaceutical supply relationship with DLA....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units. This non-set-aside, competitively awarded contract carries a ceiling value of $2,700.95 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,960.32 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the company's Corporate Office...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLCZ4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,368.29 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed-price delivery order, awarded on June 3, 2025, with completion targeted for June 4, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation, and performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Health Agency and military medical supply requirements through AmerisourceBergen's comprehensive pharmaceutical prime vendor contract. AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors, maintains an extensive federal contract portfolio with DLA that encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains. The company's significant Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026) provides the underlying authority for this and similar delivery orders to supply critical medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 6/3/25 |